Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts
Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts Professors João Gonçalves and Paolo Caliceti « Prev1 / 1Next »Optimizing Therapeutic Proteins Through PEGylation: Key Parameters and Impacts (Full Program)What Is PEGylation and...2025 Orphan Drugs: PDUFA Dates and FDA Approvals
Below is the list of important regulatory dates for all orphan drugs for 2025. Prescription Drug User Fee Act (PDUFA) dates refer to deadlines for the FDA to review new drugs. PDUFA DateOrphan DrugIndicationCompanyStatus 1.7.2025. Ryoncil...Protected: BRIGHT Phase III Trial: Evaluating Pegunigalsidase Alfa
Password Protected
To view this protected post, enter the password below: